Skip to main content
Log in

Experimental Studies of the Effects of Progesterone on the Functional Activity of P-Glycoprotein

  • MOLECULAR BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Experiments on female Chinchilla rabbits addressed the effects of progesterone on the functional activity of P-glycoprotein (Pgp). Animals were divided into four groups: animals of group 1 underwent sham operations; group 2 underwent ovariectomy; groups 3 and 4 underwent ovariectomy followed 15 days later by p.o. treatment with progesterone (2 and 15 mg/rabbit respectively). The functional activity of Pgp was determined seven days before the experiment started and on post-operative days 14, 28, and 42 by analysis of the pharmacokinetics of its marker substrate fexofenadine and serum sex hormone concentrations. At the end of the study, animals of each group were harvested by air embolism and specimens of large intestine were collected for immunohistochemical analysis. Ovariectomy led to a decrease in the functional activity of Pgp and a decrease in the staining intensity of the apical and lateral membranes of enterocytes, providing indirect evidence of a decrease in the expression of the transporter protein. Administration of progesterone at a dose of 2 mg/rabbit on the background of ovariectomy increased the functional activity of Pgp from the level seen in the ovariectomy group, though its activity remained decreased compared with the baseline level. This group showed no changes in the staining intensity of enterocyte membranes as compared with the ovariectomy group. Use of progesterone at a dose of 15 mg/rabbit after ovariectomy increased the functional activity of Pgp and the staining intensity of enterocyte apical and lateral membranes from the level seen in the ovariectomy group, restoring the level of transporter protein activity to that of intact animals, probably because of increased expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. V. G. Kukes, S. V. Grachev, D. A. Sychev, and G. V. Ramenskaya, Drug Metabolism. Scientific Basis of Personalized Medicine: Guidelines for Doctors [in Russian], GEOTAR- MEDia, Moscow (2008).

    Google Scholar 

  2. M. M. Gottesman, Annu. Rev. Med., 53, 615 – 627 (2002).

    Article  CAS  Google Scholar 

  3. H. M. Braakman, M. J. Vaessen, P. A. Hofman, et al., Epilepsia, 52, 849 – 856 (2011).

    Article  Google Scholar 

  4. W. Y. Kim and L. Z. Benet, Pharmac. Res., 21(7), 1284 – 1293 (2004).

    Article  CAS  Google Scholar 

  5. M. Frohlich, N. Albermann, A. Sauer, et al., Biochem. Pharmacol., 68(12), 2409 – 2416 (2004).

    Article  Google Scholar 

  6. M. C. Chang, Endocrinology, 79(5), 939 – 948 (1966).

    Article  CAS  Google Scholar 

  7. I. Camacho-Arroyo, A. M. Pasapera, M. A. Cerbon, Neurosci. Lett., 214(1), 25 – 28 (1996).

    Article  CAS  Google Scholar 

  8. M. V. Gatsanoga, I. V. Chernykh, A. V. Shchul’kin, and E. N. Yakusheva, Nauka Molodykh — Eruditio Juvenium, 3, 5 – 10 (2016).

  9. H. Tahara, H. Kusuhara, E. Fuse, Y. Sugiyama, Drug Metabol. Disposit., 33(7), 963 – 968 (2005).

    Article  CAS  Google Scholar 

  10. E. N. Yakusheva, I. V. Chernykh, A. V. Shchul’kin, and M. V. Gatsanoga, Ros. Med. Biol. Vestn. im. Akad. I. P. Pavlova, 3, 49 – 53 (2015).

  11. N. N. Karkishchenko, V. V. Khoron’ko, S. A. Sergeeva, and V. N. Karkishchenko, Pharmacokinetics [in Russian], Feniks, Rostov-on-Don, (2001).

  12. D. G. Fuhrich, B. A. Lessey, and R. F. Savaris, Anal. Quant. Cytopathol. Histpathol., 35(4), 210 – 216 (2013).

    PubMed  PubMed Central  Google Scholar 

  13. G. P. Vinson and I. Chester Jones, J. Endocrinol., 29, 185 – 191(1964).

  14. US Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry: Drug Interaction Studies – Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf.

  15. E. N. Yakusheva, I. V. Chernykh, A. V. Shchul’kin, et al., Ros. Fiziol. Zh. im. I. M. Sechenova, 100(8), 944 – 952 (2014).

    CAS  Google Scholar 

  16. V. Poongavanam, N. Haider, and G. F. Ecker, Bioorg. Med. Chem., 20(18), 5388 – 5395 (2012).

    Article  CAS  Google Scholar 

  17. A. Geick, M. Eichelbaum, and O. Burk, J. Biol. Chem., 276, 14581 – 14587 (2001).

    Article  CAS  Google Scholar 

  18. S. A. Kliewer, J. T. Moore, L. Wade, et al., Cell, 92(1), 73 – 82 (1998).

    Article  CAS  Google Scholar 

Download references

This study was supported by the Russian Foundation for Basic Research (Grant No. 16-04-00320a).

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 7, pp. 3 – 8, July, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shchul’kin, A.V., Chernykh, I.V., Yakusheva, E.N. et al. Experimental Studies of the Effects of Progesterone on the Functional Activity of P-Glycoprotein. Pharm Chem J 52, 587–592 (2018). https://doi.org/10.1007/s11094-018-1864-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1864-8

Keywords

Navigation